Psychiatry
Adult Autism Diagnosis
NICE CG142 — recognition, autism diagnostic instruments (ADOS, AAA, RAADS-R), comprehensive assessment, support not 'cure'.
Source: NICE CG142 (2012, updated)
Step 1 of ~3
info
Recognition
Increasing recognition in adults — many missed in childhood (especially women, those without intellectual disability). Persistent (lifelong) deficits in:
• Social communication + interaction (reciprocal conversation, non-verbal communication, relationships).
• Restricted, repetitive behaviours / interests / activities (stereotypies, insistence on sameness, intense focused interests, sensory hyper / hypo-reactivity).
• Symptoms present from early developmental period.
• Cause clinically significant impairment.
Red flags for assessment: difficulty in social interaction, sensory sensitivity, intense interests, communication difficulties, comorbid mental illness not responding as expected.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Enteral feeds · Nutritional support
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Fluorescein Sodium 2% Eye Drops · Diagnostic ophthalmic dye
- Indocyanine Green (Intravitreal Chromovitrectomy) · Diagnostic Dye — Vitreoretinal Surgery / ICG Angiography
- Lissamine Green 1% Eye Drops · Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only. Always apply local guidelines and clinical judgement.